Lipum Receives Vinnova Grant for SOL-116 Research
Lipum says it was awarded a Vinnova grant to increase knowledge of SOL-116’s biological effects.
Related stories
JELD-WEN Reports Third-Quarter 2026 Revenue of $798.5 Million
Net revenues fell 1.4% year over year to $798.5 million. The company posted a $17.2 million net loss, compared with a $367.6 million loss a year earlier, and maintained its 2026 re
M impact | EQUITY | Nov 04, 2026, 02:21 PM UTC
Enviri Exits Deutsche Bahn Contract, Expects $19 Million Gain
Enviri released Harsco Rail from its Deutsche Bahn contract after repaying approximately $73 million in advances. The company expects a net gain of approximately $19 million with t
M impact | EQUITY | Nov 04, 2026, 02:09 PM UTC
Freeport Approves $4.5 Billion Bagdad Copper Expansion
Freeport-McMoRan's board approved a $4.5 billion expansion and modernization project at its Bagdad copper and molybdenum operation in Arizona. The project is expected to more than
M impact | EQUITY | Nov 04, 2026, 02:05 PM UTC
CPI Card Group Reports Record Q3 Results, Raises 2026 Guidance
Third-quarter revenue rose 15% year over year to $158 million, net income increased 117% to $5 million and adjusted EBITDA grew 17% to $27 million. The company raised its 2026 reve
M impact | EQUITY | Nov 04, 2026, 02:05 PM UTC
Comscore Reports Q3 Revenue Down 14.3%, Targets $20M–$25M Cost Savings
Comscore reported third-quarter 2026 revenue of $76.2 million, down 14.3% year over year. Net loss was $65.5 million, including a $57.3 million non-cash goodwill impairment and $5.
M impact | EQUITY | Nov 04, 2026, 02:04 PM UTC
Sherritt to Temporarily Lay Off About 280 Canadian Employees
Sherritt says the layoffs will affect 47% of its Canadian workforce and last about 90 days as it works to preserve liquidity and restore refining operations in Fort Saskatchewan, A
M impact | EQUITY | Nov 04, 2026, 02:04 PM UTC